Skip to main content
Log in

Methylphenidate-Induced Autoimmune Hepatitis

  • Case Report
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

  1. Krawitt EL (2006) Autoimmune hepatitis. N Engl J Med 354:54–66

    Article  PubMed  CAS  Google Scholar 

  2. Lewis JH, Zimmerman H (1998) Drug induced autoimmune liver disease. In: Krawitt EL, Wiesner RH, Nishioka M (eds) Autoimmune liver disease, 2nd ed. Elsevier, Amsterdam, pp 627–649

    Google Scholar 

  3. Nietsch HH, et al. (2000) Minocycline-induced hepatitis. Am J Gastroenterol 95:2993–2994

    Article  PubMed  CAS  Google Scholar 

  4. Alla, V, et al. (2006) Autoimmune hepatitis triggered by statins. J Clin Gastroenterol 40:757--761

    Google Scholar 

  5. Sterling MJ, Kane M, Grace N (1996) Pemoline-induced autoimmune hepatitis. Am J Gastroenterol 91(10):2233–2234

    PubMed  CAS  Google Scholar 

  6. Challman TD, Lipsky J (2000) Methylphenidate: its pharmacology and uses. Mayo Clin Proc 75(7):711–721

    Article  PubMed  CAS  Google Scholar 

  7. Bader GM, Hawley J, Short D (1998) Venlafaxine augmentation with methylphenidate for treatment refractory depression: A case report. J Clin Psychopharm 18(3):255–256

    Article  CAS  Google Scholar 

  8. Plutchik L, Snyder S, Drooker M, et al. (1998) Methylphenidate in post-liver transplant patients. Psychosomatics 39:118–123

    PubMed  CAS  Google Scholar 

  9. Kalant, H (2001) The pharmacology and toxicology of “ecstasy” (MDMA) and related drugs. Can Med Assoc J 165(7):917–928

    CAS  Google Scholar 

  10. Maurer HH, et al. (2004) Chemistry, pharmacology, toxicology and hepatic metabolism of designer drugs of the amphetamine (Ecstasy), piperazine, and pyrrolidinophenone types; a synopsis. Ther Drug Monit 26(2):127–131

    Article  PubMed  CAS  Google Scholar 

  11. Jones AL, Simpson K (1999) Review article: Mechanisms and management of hepatotoxicity in ecstasy (MDMA) and amphetamine intoxications. Aliment Pharmacol Ther 13(2):129–133

    Article  PubMed  CAS  Google Scholar 

  12. Lyseng-Williamson KA, Keating GM (2002) Extended-release methylphenidate. Drugs 62(15):2251–2259

    Article  PubMed  CAS  Google Scholar 

  13. Goodman CR (1972) Hepatotoxicity due to methylphenidate hydrochloride. NY State J Med 72(18):2339–2340

  14. Mehta H, Murray B, Loludice T (1984) Hepatic dysfunction due to intravenous abuse of methylphenidate hydrochloride. J Clin Gastroenterol 6:149–151

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jason J. Lewis.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lewis, J.J., Iezzoni, J.C. & Berg, C.L. Methylphenidate-Induced Autoimmune Hepatitis. Dig Dis Sci 52, 594–597 (2007). https://doi.org/10.1007/s10620-006-9525-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-006-9525-2

Keywords

Navigation